These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12362252)

  • 1. Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.
    Guillet B; Pinganaud C; Proulle V; Dreyfus M; Lambert T
    Thromb Haemost; 2002 Oct; 88(4):698-9. PubMed ID: 12362252
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor.
    Peerlinck K; Vermylen J
    Thromb Haemost; 1999 Dec; 82(6):1775-6. PubMed ID: 10613674
    [No Abstract]   [Full Text] [Related]  

  • 3. rFVIIa (Novoseven): the new panacea?
    Ickx BE
    Acta Anaesthesiol Belg; 2003; 54(4):333-5. PubMed ID: 14719355
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant FVIIa.
    Hedner U
    Vox Sang; 2004 Jul; 87 Suppl 2():25-8. PubMed ID: 15209873
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
    Baudo F; de Cataldo F; Gaidano G;
    Haematologica; 2004 Jun; 89(6):759-61. PubMed ID: 15194550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial of haemophilia treatment for intracerebral haemorrhage.
    Lowe R
    Lancet Neurol; 2004 Aug; 3(8):448. PubMed ID: 15303268
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant factor VIIa (Novoseven) and the safety of treatment.
    Roberts HR
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):48-50. PubMed ID: 11735111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
    Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F
    Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
    Laguna P; Klukowska A
    Haemophilia; 2005 Jan; 11(1):2-4. PubMed ID: 15660981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa (r-FVIIa) in haemophilia management.
    Rice KM; Savidge GF
    Transfus Sci; 1996 Sep; 17(3):339-40. PubMed ID: 10184611
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
    Conesa V; Mompel A; Lopez F; Marín F; Ruiz J; Navarro F; Gomez A
    Am J Hematol; 2002 Aug; 70(4):329-30. PubMed ID: 12210816
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Cruz-Flores S
    Neurology; 2007 May; 68(20):1750-1; author reply 1751. PubMed ID: 17502566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M; Capra F; Capelli C; de Maria E; Lippi G; Gandini G
    Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
    [No Abstract]   [Full Text] [Related]  

  • 15. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Sugg RM; Gonzales NR; Matherne DE; Ribo M; Shaltoni HM; Baraniuk S; Noser EA; Grotta JC
    Neurology; 2006 Sep; 67(6):1053-5. PubMed ID: 17000976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.
    Hedner U; Glazer S; Pingel K; Alberts KA; Blombäck M; Schulman S; Johnsson H
    Lancet; 1988 Nov; 2(8621):1193. PubMed ID: 2903400
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
    Bui JD; Despotis GD; Trulock EP; Patterson GA; Goodnough LT
    J Thorac Cardiovasc Surg; 2002 Oct; 124(4):852-4. PubMed ID: 12324751
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
    Ng HJ; Lee LH
    Ann Acad Med Singap; 2002 Mar; 31(2):241-4. PubMed ID: 11957567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery.
    Doughty HA; Northeast A; Sklair L; Roques T; Young AE; Savidge GF; Hunt BJ
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):125-8. PubMed ID: 7605877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pemphigoid and acquired hemophilia].
    Lightburn E; Morand JJ; Graffin B; Molinier S; Raphenon G; Poullin P; Harlé JR; Chouc C
    Ann Dermatol Venereol; 2001 Nov; 128(11):1229-31. PubMed ID: 11908168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.